3D Bioprinting Market Size To Reach $6.67 Billion By 2033

April 2026 | Report Format: Electronic (PDF)

3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 6.67 billion by 2033, expanding at a CAGR of 9.71% from 2026 to 2033, according to a new report by Grand View Research, Inc. Rising cases of COVID-19 and high prevalence of chronic diseases are some of the major factors contributing to the growth. During the outbreak of the pandemic, 3D printing has stepped up to become a vital technology to support improved healthcare and emergency response.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast-tracked the development of vaccine and drug testing.

In the meantime, various 3D bioprinting companies are focused on the R&D of artificial tissues. With the help of U-FAB and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator.

The pandemic not only affected the well-being of people, but also affected the economy, and various other healthcare infrastructures worldwide. It severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situations, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to healthcare workers.

North America held the highest share of about 30.9% in 2022. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness increased technological development in the pharmaceutical and biopharmaceutical sectors.

key Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

The medical segment accounted for the largest revenue share in 2025 due to the increasing investment made in R&D.
The consumer and personal product testing segment is expected to grow at the fastest rate during the forecast period.
The magnetic levitation segment is anticipated to witness the fastest CAGR during the forecast period due to technological development, and increasing adoption of magnetic levitation techniques by various innovators.
North America dominated the market in 2025 with a share of 28.75%. Growing government expenditure on the healthcare industry is one of the major factors driving the market in this region.

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market report based on technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2021 - 2033)

Magnetic Levitation
Inkjet-based
Syringe-based
Laser-based
Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2021 - 2033)

Medical
- Tissue and organ generation
- Medical pills
- Prosthetics and implants
- Others
Dental
Biosensors
Consumer/Personal Product Testing
Bioinks
Food and Animal Product